Sudeep Pharma Management
Management criteria checks 1/4
Sudeep Pharma's CEO is Sujit Bhayani, appointed in Dec 2024, has a tenure of 1.5 years. directly owns 31.36% of the company’s shares, worth ₹26.27B. The average tenure of the management team and the board of directors is 1.6 years and 1.8 years respectively.
Key information
Sujit Bhayani
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 1.5yrs |
| CEO ownership | 31.4% |
| Management average tenure | 1.6yrs |
| Board average tenure | 1.8yrs |
Recent management updates
Recent updates
CEO
Sujit Bhayani (59 yo)
Mr. Sujit Jaysukh Bhayani is Founder of Sudeep Pharma Limited and serves as its Chairman since July 10, 2024 and serves as its MD since December 10, 2024. Mr. Bhayani joined the Sudeep Pharma Limited on Ap...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Financial Officer | 1.8yrs | ₹6.10m | no data | |
| Senior General Manager of Accounts & Finance | no data | ₹4.54m | no data | |
| Senior Manager of Human Resources & Administration | 3.8yrs | ₹1.69m | no data | |
| Company Secretary & Compliance Officer | 1.5yrs | ₹420.00k | no data | |
| Managing Director of Sudeep Pharma B.V | 2.6yrs | ₹19.46m | no data | |
| GM & Site Head | 1.5yrs | ₹2.69m | no data | |
| Vice President of Sales and Supply Chain Sudeep Pharma USA Inc | no data | ₹25.52m | no data | |
| Vice President of Business Development - Sudeep Advanced Materials Private Limited | 1.9yrs | ₹27.05m | no data | |
| Founder | 1.5yrs | ₹22.98m | 31.36% ₹ 26.3b | |
| Whole-Time Director | 1.5yrs | ₹9.00m | 4.45% ₹ 3.7b | |
| Whole-Time Director | 1.8yrs | no data | no data | |
| Managing Director of Sudeep Pharma USA Inc. | less than a year | no data | no data |
Experienced Management: SUDEEPPHRM's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 35.2yrs | ₹22.98m | 31.36% ₹ 26.3b | |
| Whole-Time Director | 4.5yrs | ₹9.00m | 4.45% ₹ 3.7b | |
| Whole-Time Director | 1.8yrs | no data | no data | |
| Independent Director | 1.8yrs | ₹470.00k | no data | |
| Independent Director | 1.8yrs | ₹480.00k | no data | |
| Independent Director | 1.8yrs | ₹430.00k | no data | |
| Independent Director | 1.8yrs | ₹430.00k | no data |
Experienced Board: SUDEEPPHRM's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/09 01:02 |
| End of Day Share Price | 2026/06/09 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2026/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Sudeep Pharma Limited is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Sanjesh Jain | ICICI Securities Ltd. |
| Swarnendu Bhushan | Prabhudas Lilladher Pvt Ltd. |